References
- Turc J, Lamblin A, Vitry T, et al. Clinical diagnosis of invasive pulmonary aspergillosis in a non-neutropenic critically ill patient. Resp Care. 2014;59(9):137–45.
- Falcone M, Concia E, Iori I, et al. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med. 2014;9:501–511.
- Nataloni S, Gabbanelli V, Rossi R, et al. Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in intensive care unit. Minerva Anestesiol. 2007;73:371–375.
- Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007;33:1694–1703.
- Hartemink KJ, Paul MA, Spijkstra JJ, et al. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med. 2003;29:2068–2071.
- Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am. 2008;55(3):647–xi.
- Kosmidis C, Denning D. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270–277.
- Kaiser P, Thurnheer R, Krause M, et al. Invasive aspergillosis in non-neutropenic patients. Eur J Intern Med. 2009;20:e131–e133.
- Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis. 1998;26:1473–1475.
- Garcia RJ, Troya P, Edwards C. Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review. South Med J. 2006;99(6):607–610.
- Sahlen AO, Survarna SK, Wilkie ME. A case of invasive pulmonary aspergillosis in renal failure. Nephrol Dial Transplant. 2004;19:2687.
- Marr KA. Epidemiology and clinical manifestations of invasive aspergillosis. In: UpToDate, Post TW, editor. UpToDate. Waltham (MA). 2015. Available from: http://www.uptodate.com/contents/epidemiology-and-clinical-manifestations-of-invasive-aspergillosis
- ter Maaten JC, Golding RP, Strack van Schijndel RJ, et al. Disseminated aspergillosis after near-drowning. Neth J Med. 1995;47:21–24.
- Leroy P, Smismans A, Seute T. Invasive pulmonary and central nervous system aspergillosis after near-drowning of a child: case report and review of the literature. Pediatrics. 2006;118:e509–e513.
- Alexander J. Introductory remarks: overview of NDA 207,500 and 207,501 Isavuconazonium. Anti-Infective Drugs Advisory Committee Meeting; 2015. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM431845.pdf
- Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist. 2013;6:163–174.